Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.

Recent Press Releases

June 17, 2013 - 4:30 p.m.
Gilead Sciences to Present at the Wells Fargo Securities 2013 Healthcare Conference on Tuesday, June 18Printer Friendly Version 
June 17, 2013 - 4:00 a.m.
Gilead Announces Interim Phase 2 Data for Idelalisib Showing Response in Refractory Indolent Non-Hodgkin’s LymphomaPrinter Friendly Version 
June 10, 2013 - 4:31 p.m.
Gilead Sciences to Present at the Goldman Sachs 34th Annual Healthcare Conference on Tuesday, June 11Printer Friendly Version 

Upcoming Events

Tuesday, June 18, 2013 10:35 a.m. ET
Gilead Sciences Inc at Wells Fargo Securities Research & Economics 2013 Healthcare Conference
Wednesday, June 19, 2013 through Saturday, June 22, 2013
12th International Conference on Malignant Lymphoma
Friday, June 21, 2013 through Tuesday, June 25, 2013
American Diabetes Association 73rd Scientific Sessions

Most Viewed Links

Updated 06/19/13
1.Stock Information
2.SEC Filings
3.Stock Quote
4.Annual Reports
5.Fundamentals - Snapshot
* Data collected 06/11/13 - 06/18/13

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$51.94
 Stock is Up 0.91 (1.78%)
Data as of 06/18/13 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Webcast Replay
36th European Cystic Fibrosis Society Conference

June 12, 2013 through June 15, 2013
Play
First Quarter 2013 Gilead Sciences Earnings Conference Call

May 02, 2013 4:30 p.m. ET
Play